Click on a filter below to refine your search. Remove a filter to broaden your search.
At 30 days after discharge, the mortality rate was 3.2% and skilled nursing facility use rate was 2.6%.
19.05 million deaths were estimated for CVD globally in 2020, representing an increase of 18.71% from 2010.
The benefits for heart failure patients include functional capacity and fewer complications with newer devices.
Findings seen regardless of whether hypertension persists in seated position
Half of the participants reported at least one severe cardiovascular condition; the overall mortality rate was 19.8%.
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
A reduced risk was seen for venous thromboembolism, arterial thrombosis/thromboembolism and heart failure.
Dapagliflozin, however, does not reduce the urinary albumin-to-creatinine ratio in those patients.